The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Antigen spread and survival with sipuleucel-T in patients with advanced prostate cancer.
Charles G. Drake
Consultant or Advisory Role - Bristol-Myers Squibb; Compugen; Dendreon; Pfizer
Stock Ownership - Amplimmune
Research Funding - Bristol-Myers Squibb; Janssen-Ortho
Li-Qun Fan
Employment or Leadership Position - Dendreon
Debraj GuhaThakurta
Employment or Leadership Position - Dendreon
Stock Ownership - Dendreon
Frances Stewart
Employment or Leadership Position - Dendreon
Stock Ownership - Dendreon
Philip W. Kantoff
Research Funding - Dendreon
Eric Jay Small
Research Funding - Dendreon
Thomas A. Gardner
Consultant or Advisory Role - Dendreon
Honoraria - Dendreon
Research Funding - Dendreon
Nadeem A. Sheikh
Employment or Leadership Position - Dendreon
Stock Ownership - Dendreon
James B. Trager
Employment or Leadership Position - Dendreon
Stock Ownership - Dendreon
Celestia S. Higano
Consultant or Advisory Role - Dendreon
Research Funding - Dendreon
Other Remuneration - Dendreon